Health Care & Insurance

Lilly product gets boost; Wall Street yawns

January 26, 2011
J.K. Wall
Eli Lilly and Co. probably will get approval for its newly acquired imaging agent used to diagnose Alzheimer’s disease, but so far analysts are unimpressed.
More

WellPoint profit better than analyst estimates

January 26, 2011
Bloomberg News, J.K. Wall
Excluding special charges, WellPoint’s profit fell 2 percent to $524.7 million in the fourth quarter from $536 million in the fourth quarter of 2009. But earnings per share improved thanks to stock buybacks.
More

Head of Lilly's oncology unit resigning

January 25, 2011
John H. Johnson has been hired as CEO by East Brunswick, N.J.-based biotechnology company Savient Pharmaceuticals Inc.
More

State lawmakers to take on unemployment insurance

January 24, 2011
Associated Press
Businesses with a history of laying off employees would pay more in unemployment insurance costs, and workers in industries where layoffs occur regularly would receive lower benefits under a bill Indiana lawmakers are preparing to take up.
More

Vanderbilt rejected by high court on Cialis patents

January 24, 2011
Bloomberg News
Supreme Court justices on Monday left intact a ruling throwing out a lawsuit pressed by the Nashville, Tenn., university against Eli Lilly's Icos subsidiary.
More

Zionsville retirement village plans $32 million expansion

January 24, 2011
 IBJ Staff
Hoosier Village Retirement Center in Zionsville announced plans Monday morning for a $32 million project that will expand its campus and allow the center to add 50 full-time workers.
More

Indiana companies prepping for burst of acquisitions

January 22, 2011
Francesca Jarosz
Conditions are ripe for a barrage of mergers and acquisitions to take place this year.
More

Uptick in M&A activity suggests a turnaroundRestricted Content

January 22, 2011
Scott Olson
Fourth quarter helps to bolster 2010 deal-making.
More

Lilly seeks to block imports of cancer drug copy

January 21, 2011
Bloomberg News
The local drugmaker told the International Trade Commission on Thursday that the generic version of Gemzar violates its patent on the process for making the active ingredient.
More

Lilly imaging drug fails to win FDA panel's backing

January 21, 2011
Bloomberg News
Eli Lilly and Co.'s Amyvid isn't ready to be approved to detect Alzheimer's-related deposits in the brain, according to FDA advisors. The medicine could still be approved if Lilly establishes a training program and a way to ensure that the results of brain scans are read consistently, they said.
More

Daniels' budget proposal wouldn't cut hearing aids

January 19, 2011
Associated Press
State budget director Adam Horst said he misspoke when he told the State Budget Committee last week that Daniels&' proposal would eliminate Medicaid coverage for hearing aids.
More

Evans dreams big as Clarian becomes IU Health

January 19, 2011
J.K. Wall
Clarian Health, which is set to change its name to Indiana University Health on Jan. 24, is relying on the academic expertise of its downtown Indianapolis hospitals to pull in patients from a wider swath of the state and the nation.
More

Down on luck, Lilly finds comfort in pets

January 19, 2011
J.K. Wall
Eli Lilly and Co. continues to misfire on getting new human medicines approved, but its animal health unit is on a roll.
More

Carmel firm gets FDA approval for lice treatment

January 18, 2011
 IBJ Staff
ParaPRO LLC's treatment, called Natroba, has a potential U.S. market of 6 million to 12 million infected children annually.
More

Health chief: Indiana needs more trauma center access

January 18, 2011
Associated Press
State Health Commissioner Greg Larkin says much of Indiana lacks the access to hospital trauma centers needed to treat victims of attacks like the one in Tucson that left U.S. Rep. Gabrielle Giffords of Arizona critically injured.
More

Lilly imaging drug isn't ready for approval, FDA says

January 18, 2011
Eli Lilly and Co.’s experimental drug to help identify plaque in the brain tied to Alzheimer's disease isn't ready for approval, according to U.S. regulators.
More

Community Health plans $12M east-side medical complex

January 17, 2011
Construction is set to begin soon on Community Health Pavilion, a three-story, 55,000-square-foot medical building to be built on six acres at 7910 E. Washington St.
More

WellPoint headquarters snags $42M

January 15, 2011
Cory Schouten
Massachusetts-based Franklin Street Properties acquired the Monument Circle headquarters of insurance giant WellPoint Inc. late in 2010 for $42 million—a rich $196 per square foot—from an affiliate of locally based HDG Mansur.
More

By wide margin, Anthem still city's largest insurerRestricted Content

January 15, 2011
Scott Olson
Anthem Blue Cross and Blue Shield's share of the Indianapolis area has leveled off, even though it still insures more than half the commercial market—or three times as much as its nearest competitor.
More

Can video games be good for your health?

January 15, 2011
J.K. Wall
Local companies are embedding stealthy video messages for high school and college students.
More

LAMKIN: Health care reform is opportunity to reorganize servicesRestricted Content

January 15, 2011
Ned Lamkin
Indiana should take advantage of the opportunity to build a comprehensive exchange.
More

Endocyte prices IPO stock

January 14, 2011
J.K. Wall
The West Lafayette-based drug development firm intends to sell 6.15 million shares for $13 to $15 apiece. That would fetch $80 million to $92 million.
More

Panel says Lilly’s Solpura isn’t ready for approval

January 12, 2011
Bloomberg News
Eli Lilly and Co. failed to win an FDA advisory panel’s recommendation to introduce the first pancreatic enzyme that isn’t derived from pig parts.
More

Roche back in court as partner looks to sell to competitor

January 12, 2011
J.K. Wall
Roche Diagnostics requested a temporary restraining order against Medical Automation Systems Inc. Tuesday after receiving word the company is speeding up plans to sell itself to Roche rival Alere Inc.
More

Deal could give Lilly full diabetes deck

January 12, 2011
J.K. Wall
Eli Lilly and Co.'s diabetes partnership with Boehringer Ingelheim GmbH represents a new kind of disease-focused strategy that some consultants think is key to pharma companies’ futures.
More
Page  << 51 52 53 54 55 56 57 58 59 60 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT